Cargando…
System-based approaches as prognostic tools for glioblastoma
BACKGROUND: The evasion of apoptosis is a hallmark of cancer. Understanding this process holistically and overcoming apoptosis resistance is a goal of many research teams in order to develop better treatment options for cancer patients. Efforts are also ongoing to personalize the treatment of patien...
Autores principales: | Salvucci, Manuela, Zakaria, Zaitun, Carberry, Steven, Tivnan, Amanda, Seifert, Volker, Kögel, Donat, Murphy, Brona M., Prehn, Jochen H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852738/ https://www.ncbi.nlm.nih.gov/pubmed/31718568 http://dx.doi.org/10.1186/s12885-019-6280-2 |
Ejemplares similares
-
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
por: Tivnan, Amanda, et al.
Publicado: (2015) -
Advances in immunotherapy for the treatment of glioblastoma
por: Tivnan, Amanda, et al.
Publicado: (2016) -
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
por: Zakaria, Z, et al.
Publicado: (2016) -
The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer
por: Carberry, Steven, et al.
Publicado: (2018) -
TGF-β1 activates two distinct type I receptors in neurons: implications for neuronal NF-κB signaling
por: König, Hans-Georg, et al.
Publicado: (2005)